Clinical Trial Update: A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating donor regulatory T-cells for treatment of chronic graft-versus-host disease refractory to steroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Donor regulatory T-cells

Snippet

Sponsor: Instituto de Medicina Molecular João Lobo Antunes | Conditions: Graft vs Host Disease | Phase 1, Phase 2 | Status: UNKNOWN